Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology
Cancer Medicine · 2024
DOI: 10.1002/cam4.7398 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2024. Verfasst von Gregor Duwe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany. Hauptthemen laut MEDLINE: Artificial Intelligence, Medical Oncology, Neoplasms, Clinical Decision-Making. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Artificial intelligence (AI) promises to be the next revolutionary step in modern society. Yet, its role in all fields of industry and science need to be determined. One very promising field is represented by AI‐based decision‐making tools in clinical oncology leading to more comprehensive, personalized therapy approaches. In this review, the authors provide an overview on all relevant technical applications of AI in oncology, which are required to understand the future challenges and realistic perspectives for decision‐making tools. In recent years, various applications of AI in medicine have been developed focusing on the analysis of radiological and pathological images. AI applications encompass large amounts of complex data supporting clinical decision‐making and reducing errors by objectively quantifying all aspects of the data collected. In clinical oncology, almost all patients receive a treatment recommendation in a multidisciplinary cancer conference at the beginning and during their treatment periods. These highly complex decisions are based on a large amount of information (of the patients and of the various treatment options), which need to be analyzed and correctly classified in a short time. In this review, the authors describe the technical and medical requirements of AI to address these scientific challenges in a multidisciplinary manner. Major challenges in the use of AI in oncology and decision‐making tools are data security, data representation, and explainability of AI‐based outcome predictions, in particular for decision‐making processes in multidisciplinary cancer conferences. Finally, limitations and potential solutions are described and compared for current and future research attempts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
- Research Unit Smart Data and Knowledge Services, German Research Center for Artificial Intelligence, Kaiserslautern, Germany.
- Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Urology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
ORCID-Profile: Gregor Duwe
Förderung
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Duwe, G., Mercier, D., Wiesmann, C., Kauth, V., Moench, K., Junker, M., Neumann, C. C. M., Haferkamp, A., Dengel, A., & Höfner, T. (2024). Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology. Cancer Medicine. https://doi.org/10.1002/cam4.7398
Vancouver
Duwe G, Mercier D, Wiesmann C, Kauth V, Moench K, Junker M, et al. Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology. Cancer Medicine. 2024. doi:10.1002/cam4.7398
BibTeX
@article{Duwe2024,
author = {Duwe, Gregor and Mercier, Dominique and Wiesmann, Crispin and Kauth, Verena and Moench, Kerstin and Junker, Markus and Neumann, Christopher C M and Haferkamp, Axel and Dengel, Andreas and Höfner, Thomas},
title = {Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7398}
}
EUVIMED